Summary
The ocular penetration of topically applied [14C]-atenolol in the rabbit was determined by means of liquid scintillation counting. Only one eye was treated, the fellow eye serving as a control. Blood plasma levels were measured as well.
The absolute amount of atenolol which penetrated the eye was very low, but a relatively high concentration was achieved in the tissues of the nictitating membrane. We could only detect an increase in the amount of atenolol with time in the aqueous humor. In all other ocular tissues, including iris and ciliary body, the atenolol level remained constant with time. Hardly any atenolol could be detected in the untreated eye and none in the blood plasma.
These findings suggest that the ocular penetration of atenolol administered as an eye drop is very poor. Ocular penetration, therefore, hardly seems to play a part in the antiglaucomatous effect of atenolol.
Similar content being viewed by others
References
Barrett, A.M.: The pharmacology of atenolol. Postgrad. Med. J. 53, 58–64 (1977)
Brenkman, R.F.: Ocular hypotensive effect of atenolol 4% eye drops in glaucoma. In: Symposium on Medical Therapy in Glaucoma (ed. Greve, E.L.) Docum. Ophthal. Proceedings Series, Vol. 12, 85–94. The Hague: Junk 1977
Brogden, R.N., Heel, R.C., Speight, T.M., Avery, G.S.: Metoprolo: a review of its pharmacological properties and therapeutic efficiency in hypertension and angina pectoris. Drugs. 14, 321–348 (1977)
Brown, H.C., Carruthers, S.G., Johnston, G.D., Kelly, J.G., McAinsh, J., McDevitt, D.G., Shanks, R.G.: Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker. Clin. Pharmacol. Ther. 20, 524–536 (1976)
Elliot, M.J., Cullen, P.M.Phillips, C.I.: Ocular hypotensive effect of atenolol (Tenormin®, I.C.I.) A new beta-adrenergic blocker. Br. J. Ophthalmol. 59, 296–300 (1975)
MacDonald, M.J., Cullen, P.M., Phillips, C.I.: Atenolol versus propanolol. Br. J. Ophthalmol. 60, 789–791 (1976)
MacDonald, M.J., Gore, S.M., Cullen, P.M., Phillips, C.I.: Comparison of the ocular hypotensive effects of acetazolamide and atenolol. Br. J. Ophthalmol. 61, 345–348 (1977)
Phillips, C.I., Gore, S.M., MacDonald, M.J., Cullen, P.M.: Atenolol eye drops in glaucoma. A double masked, controlled study. Br. J. Ophthalmol. 61, 349–353 (1977)
Ros, F.E., Dake, C.L., Offerhaus, L., Greve, E.L.: Atenolol 4% eye drops and glaucoma. Albrecht v. Graefes Arch. klin. exp. Ophthal. 205, 61–70 (1977)
Ros, F.E., Dake, C.L., Nagelkerke, N.D., Greve, E.L.: Metoprolol eye drops in the treatment of glaucoma. Albrecht v. Graefes Arch. klin. exp. Ophthal. 206, 247–254 (1978)
Wettrell, K., Pandolfi, M.: Effect of topical atenolol on intraocular pressure. Br. J. Ophthalmol. 61, 334–338 (1977)
Zimmerman, Th.J., Kaufman, H.E.: Timolol. A beta adrenergic blocking drug for the treatment of glaucoma. Arch. Ophthalmol. 95, 601–604 (1977a)
Zimmerman, Th.J., Kaufman, H.E.: Timolol. Dose response and duration of action. Arch. Ophthalmol. 95, 605–607 (1977b)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ros, F.E., Innemee, H.C. & van Zwieten, P.A. Penetration of atenolol in the rabbit eye. Albrecht von Graefes Arch. Klin. Ophthalmol. 208, 235–240 (1978). https://doi.org/10.1007/BF00419378
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00419378